BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 30099529)

  • 1. Clinical Practice Guideline for the Medical Management of Perianal Fistulizing Crohn's Disease: The Toronto Consensus.
    Steinhart AH; Panaccione R; Targownik L; Bressler B; Khanna R; Marshall JK; Afif W; Bernstein CN; Bitton A; Borgaonkar M; Chauhan U; Halloran B; Jones J; Kennedy E; Leontiadis GI; Loftus EV; Meddings J; Moayyedi P; Murthy S; Plamondon S; Rosenfeld G; Schwartz D; Seow CH; Williams C
    Inflamm Bowel Dis; 2019 Jan; 25(1):1-13. PubMed ID: 30099529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological Therapies for the Management of Fistulizing Crohn's Disease: A Systematic Review and Meta-Analysis.
    Vuyyuru SK; Solitano V; Narula N; Lee MJ; MacDonald JK; McCurdy JD; Singh S; Ma C; Jairath V
    J Crohns Colitis; 2024 Apr; 18(4):589-603. PubMed ID: 37933849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recommendations for Standardizing MRI-based Evaluation of Perianal Fistulizing Disease Activity in Pediatric Crohn's Disease Clinical Trials.
    Crowley E; Ma C; Guizzetti L; Zou G; Lewindon PJ; Gee MS; Hyams JS; Rosen MJ; von Allmen D; de Buck van Overstraeten A; Shackelton LM; Remillard J; Schleicher L; Dillman JR; Rimola J; Taylor SA; Fletcher JG; Church PC; Feagan BG; Griffiths AM; Jairath V; Greer MC
    Inflamm Bowel Dis; 2024 Mar; 30(3):357-369. PubMed ID: 37524088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical characteristics and prognosis of children with perianal fistulizing Crohn's disease].
    Fang YH; Luo YY; Zhang RF; Cheng Q; Chen J
    Zhongguo Dang Dai Er Ke Za Zhi; 2024 Jan; 26(1):42-47. PubMed ID: 38269458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of Perianal Fistulizing Crohn's Disease.
    Singh A; Midha V; Kochhar GS; Shen B; Sood A
    Inflamm Bowel Dis; 2023 Sep; ():. PubMed ID: 37672347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-screening questionnaire for perianal fistulizing disease in patients with Crohn's disease.
    Kweon OS; Kang B; Lee YJ; Kim ES; Kim SK; Lee HS; Chung YJ; Kim KO; Jang BI;
    Korean J Intern Med; 2024 May; 39(3):430-438. PubMed ID: 38576234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perianal fistulizing Crohn's disease: Current perspectives on diagnosis, monitoring and management with a focus on emerging therapies.
    Devi J; Ballard DH; Aswani-Omprakash T; Parian AM; Deepak P
    Indian J Gastroenterol; 2024 Feb; 43(1):48-63. PubMed ID: 38308773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vedolizumab for perianal fistulizing Crohn's disease: systematic review and meta-analysis.
    Ayoub F; Odenwald M; Micic D; Dalal SR; Pekow J; Cohen RD; Rubin DT; Sakuraba A
    Intest Res; 2022 Apr; 20(2):240-250. PubMed ID: 35124951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Canadian Association of Gastroenterology Clinical Practice Guideline for the Medical Management of Pediatric Luminal Crohn's Disease.
    Mack DR; Benchimol EI; Critch J; deBruyn J; Tse F; Moayyedi P; Church P; Deslandres C; El-Matary W; Huynh H; Jantchou P; Lawrence S; Otley A; Sherlock M; Walters T; Kappelman MD; Sadowski D; Marshall JK; Griffiths A
    J Can Assoc Gastroenterol; 2019 Aug; 2(3):e35-e63. PubMed ID: 31294379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perianal fistulizing Crohn's disease-associated anorectal and fistula cancers: systematic review and expert consensus.
    Wong SY; Rowan C; Brockmans ED; Law CC; Giselbrecht E; Ang C; Khaitov S; Sachar D; Winata LS; Verstockt B; Spinelli A; Rubin DT; Deepak P; McGovern DPB; McDonald BD; Lung P; Lundby L; Lightner AL; Holubar SD; Hanna L; Hamarth C; Geldof J; Dige A; Cohen BL; Carvello M; Bonifacio C; Bislenghi G; Behrenbruch C; Ballard DH; Altinmakas E; Sebastian S; Tozer P; Hart A; Colombel JF
    Clin Gastroenterol Hepatol; 2024 Jun; ():. PubMed ID: 38871152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness and safety of darvadstrocel in patients with complex perianal fistulizing Crohn's disease: a systematic review.
    Fousekis FS; Mpakogiannis K; Lianos GD; Koukoudis A; Christodoulou DK; Papaconstantinou I; Katsanos KH
    Ann Gastroenterol; 2024; 37(1):46-53. PubMed ID: 38223244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Higher Adalimumab Concentration is Associated with Complete Fistula Healing in Patients with Perianal Fistulizing Crohn's Disease.
    Papamichael K; Centritto A; Guillo L; Hier J; Sherman Z; Cheifetz AS;
    Clin Gastroenterol Hepatol; 2024 Apr; ():. PubMed ID: 38692557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient-Reported Outcomes Measures in Perianal Fistulizing Crohn's Disease.
    Queiroz NSF; Garcia KS; Miranda EF; Kotze PG
    Rev Recent Clin Trials; 2022 Apr; ():. PubMed ID: 35469573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Medical Management of Paediatric Crohn's Disease: an ECCO-ESPGHAN Guideline Update.
    van Rheenen PF; Aloi M; Assa A; Bronsky J; Escher JC; Fagerberg UL; Gasparetto M; Gerasimidis K; Griffiths A; Henderson P; Koletzko S; Kolho KL; Levine A; van Limbergen J; Martin de Carpi FJ; Navas-López VM; Oliva S; de Ridder L; Russell RK; Shouval D; Spinelli A; Turner D; Wilson D; Wine E; Ruemmele FM
    J Crohns Colitis; 2020 Oct; ():. PubMed ID: 33026087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Geldof Expert Consensus Classification of Perianal Fistulizing Crohn's Disease: A Real-World Application in a Serial Fistula MRI Cohort.
    Schroeder M; Abushamma S; George AT; Balakrishna R; Hickman J; Elumalai A; Wise P; Zulfiqar M; Ludwig DR; Shetty A; Viswanath SE; Luo C; Sebastian S; Ballard DH; Deepak P
    medRxiv; 2024 Feb; ():. PubMed ID: 38352377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correction to: Comparative Efficacy of Biologic Therapies for Inducing Response and Remission in Fistulizing Crohn's Disease: Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.
    Inflamm Bowel Dis; 2023 Dec; 29(12):2011-2012. PubMed ID: 37877812
    [No Abstract]   [Full Text] [Related]  

  • 17. Unraveling the Place of Small Molecules in the Treatment of Fistulizing Crohn's Disease-A Systematic Review and Network Meta-Analysis.
    Attauabi M; Rasmussen DN; Bergenheim FO; Burisch J; Seidelin JB
    Crohns Colitis 360; 2023 Oct; 5(4):otad074. PubMed ID: 38130950
    [No Abstract]   [Full Text] [Related]  

  • 18. Authors' Reply to Unraveling the Place of Small Molecules in the Treatment of Fistulizing Crohn's Disease-A Systematic Review and Network Meta-analysis.
    Singh A; Midha V; Kochhar GS; Shen B; Sood A
    Crohns Colitis 360; 2023 Oct; 5(4):otad075. PubMed ID: 38130949
    [No Abstract]   [Full Text] [Related]  

  • 19. ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 2: IBD scores and general principles and technical aspects.
    Sturm A; Maaser C; Calabrese E; Annese V; Fiorino G; Kucharzik T; Vavricka SR; Verstockt B; van Rheenen P; Tolan D; Taylor SA; Rimola J; Rieder F; Limdi JK; Laghi A; Krustiņš E; Kotze PG; Kopylov U; Katsanos K; Halligan S; Gordon H; González Lama Y; Ellul P; Eliakim R; Castiglione F; Burisch J; Borralho Nunes P; Bettenworth D; Baumgart DC; Stoker J;
    J Crohns Colitis; 2019 Mar; 13(3):273-284. PubMed ID: 30137278
    [No Abstract]   [Full Text] [Related]  

  • 20. [Updated S3-Guideline Colitis ulcerosa. German Society for Digestive and Metabolic Diseases (DGVS) - AWMF Registry 021/009].
    ;
    Z Gastroenterol; 2018 Sep; 56(9):1087-1169. PubMed ID: 30206914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.